|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002351,
umls-concept:C0021311,
umls-concept:C0026336,
umls-concept:C0026565,
umls-concept:C0040284,
umls-concept:C0105810,
umls-concept:C0220825,
umls-concept:C0229671,
umls-concept:C0242485,
umls-concept:C0319629,
umls-concept:C0392762,
umls-concept:C0441655,
umls-concept:C0441889,
umls-concept:C0591833,
umls-concept:C1142738,
umls-concept:C2828008
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-3-20
|
|
pubmed:abstractText |
Experience with anidulafungin against Candida krusei is limited. Immunosuppressed mice were injected with 1.3 x 10(7) to 1.5 x 10(7) CFU of C. krusei. Animals were treated with saline, 40 mg/kg fluconazole, 1 mg/kg amphotericin B, or 10 and 20 mg/kg anidulafungin for 5 days. Anidulafungin improved survival and significantly reduced the number of CFU/g in kidneys and serum beta-glucan levels.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-12490683,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-15155194,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16028162,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16080087,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16086652,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16261306,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16758414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16779750,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16801435,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-16954319,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17307976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17325225,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17341444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17482982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17568028,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-17806055,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139291-18077633
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1098-6596
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1639-41
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19139291-Animals,
pubmed-meshheading:19139291-Antifungal Agents,
pubmed-meshheading:19139291-Candida,
pubmed-meshheading:19139291-Candidiasis,
pubmed-meshheading:19139291-Disease Models, Animal,
pubmed-meshheading:19139291-Echinocandins,
pubmed-meshheading:19139291-Kidney,
pubmed-meshheading:19139291-Male,
pubmed-meshheading:19139291-Mice,
pubmed-meshheading:19139291-beta-Glucans
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
|
|
pubmed:affiliation |
Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, Texas 77030, USA. Luis.Ostrosky-Zeichner@uth.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
